Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Single Ascending Dose Trial of CVL-936 in Healthy Subjects

The aim of this trial is to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CVL-936 following single ascending oral doses in healthy subjects.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - CVL-936

CVL-936

Drug - Matching Placebo

Placebo matching CVL-936

Additional Information

Official Study Title

A Phase 1, Double-Blind, Sponsor-Open, Placebo-Controlled, First-In-Human Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Ascending Doses of CVL-936 In Healthy Subjects

Clinical Trial ID

NCT04232878

ParticipAid ID

dR6p0d